Mohammad Dahrouj, MD, PhD
Originally from Lebanon, Dr. Dahrouj earned his BS in 2007 from the American University of Beirut (AUB). He earned his MD and PhD in 2015 through a combined program at AUB and the Medical University of South Carolina (MUSC). He spent his first two years of medical school at AUB, where he was the National Officer on Research Exchange for the Lebanese Medical Student International Committee, and acted as chair of a research day in 2010. He also organized several research workshops for medical students, and was elected to the student representative committee for the faculty of medicine and acted as a secretary in the cabinet. He then transferred to MUSC to complete his degrees, during which time he was a Presidential Scholar, Chair of the Medical Scientist Program Seminars, and an Institution Representative for the American Physician Scientist Association at MUSC. He was actively involved in research and was inducted into Alpha Omega Alpha. His research focused on the role of retinal pigment epithelium in the development of diabetic macular edema and investigated c-type natriuretic peptides as a potential therapy for diabetic macular edema. His work has been published in several peer-reviewed journals, such as Experimental Eye Research, IOVS, and The Journal of Pharmacology and Experimental Therapeutics, and he has presented at many conferences, including the Association for Research in Vision and Ophthalmology and the National MD/PhD Student Conference. He has been a reviewer for PLOS ONE, and has dedicated time to the Fight for Sight Clinic. He completed his transitional year internship at Indiana University.
Harvard Catalyst Profile